A test that rapidly identifies which genetic mutations have caused a cancer could pave the way for personalised treatments to improve patients’ chances of survival. Doctors in the US have developed a way to test patients for a wide range of gene variants simultaneously, allowing them to provide more effective, targeted therapy within a matter of weeks.
